MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD9 Codes        Equipment        Hospitals        Drugs        More..
  

Useful Websites

Medical Tourism
Compare and save on surgery

Global Translations
Medical and Clinical Translation

specialistinfo.com
Details of over 40,000 UK Specialists and over 42,000 GPs

Global RPH
medical software

Doctors Lounge
Ask a Doctor and Disease Information

Health News
from Medical News Today.

MRCP 1 Revision
123 Doc medical courses for junior doctors.

CoreyNahman
pharmaceutical news daily

Hospital Search
Worldwide hospital database, search by country or keyword.

Metric Conversions
The Converter Site - unit conversion tool.
headlines news headlines   email email to a friend   printer printer friendly   newsletter sign up to newsletter  

Evolvability could be a driving force in drug resistance

Main Category: Infectious Diseases / Bacteria / Viruses

Article Date: 10 Aug 2004

Not only has life evolved, but life has evolved to evolve.

That's the conclusion drawn by two Rice University scientists who have designed a computer simulation to test the idea that evolvability -- the likelihood of genetic mutation -- is a trait that can itself be favored or disfavored through the process of natural selection.

The results of the study appear in the Aug. 10 issue of Proceedings of the National Academy of Sciences.

Researchers Michael Deem, the John W. Cox Professor of Bioengineering and professor of physics and astronomy, and David Earl, Deem's post-doctoral research fellow, drew their conclusions from a sophisticated computer simulation that recorded how much and how rapidly proteins mutated based on external changes in their environment. As the researchers ramped up the frequency and severity of environmental changes -- imagine rapid shifts between heat waves and cold snaps or heavy rains and droughts -- they saw an increased likelihood of survival among proteins that mutated more frequently.

"Selection for evolvability would help explain a growing body of experimental results including the evolution of drug resistance in bacteria, the fact that some immune system cells mutate much more rapidly than other cells in our bodies, as well as why some bacteria and higher-order organisms have a tendency to transpose or swap relatively long sequences of DNA," said Deem.

Traditionally, a significant number of evolutionary biologists have discounted the idea that evolvability is subject to natural selection, in part because the idea that evolution acts upon the mechanism that causes evolution seems to violate the basic scientific principle that an event cannot precede its own cause.

But Deem and Earl argue that causal violations need not occur. For one thing, there are several different ways that genetic mutations occur. Random changes along the DNA chain are now understood to be only one way that organisms evolve. Mutations also occur based on genetic recombination, genetic transposition and horizontal gene transfer. With these mechanisms, relatively large chunks of genetic code are shuffled or substituted for one another along the DNA chain.

Deem and Earl's argument centers on the idea that the ability to reorder genes or to cause large-scale genetic change are themselves genetic traits, traits that are subject to selection like any others.

The upshot of this is that many observations within evolutionary biology that were heretofore considered evolutionary happenstance or accidents, may in fact be explained by selection for evolvability.

Two primary examples of this can be found in the escalating "arms race" that has been documented between pathogens and the immune systems in people and other higher-order vertebrates. Deem and Earl argue that wide variation among bacteria and other antigens has put selective pressure on our immune systems to rapidly adapt methods of identifying and attacking invaders. Similar observations on the rapid mutability among flu viruses and other invading pathogens provide additional evidence, they said.

"The implication is that the drugs we have developed to fight invading pathogens also confer selective pressure on the evolvability of the pathogens themselves," Earl said. "In drug design, it is important to consider this and to look for ways to minimize or counteract this driving force for drug resistence."

The research is supported by the National Institutes of Health.

Contact: Jade Boyd
jadeboyd@rice.edu
713-348-6778
Rice University

Original article posted on Medical News Today.
Articles not to be reproduced without permission of Medical News Today

Medical News Today publishes the latest health news and health videos for consumers and health professionals. It has a searchable archive of over 100,000 health news articles.





For any corrections of factual information, or to contact the editors please use our feedback form.
Send your press releases to








free web search box


pda medical dictionary
pda software - $15

PDA Medical Dictionary

only $15

Take MediLexicon's abbreviations search with you where-ever you go with our PDA software. As an extra, this software is available with an extra medical dictionary...

>> Click here for more on the PDA Medical Dictionary <<




add to google

Add our searches to your Google homepage.

Add to Google

The 60 seconds challenge: Add these searches to your Google homepage within 60 seconds - simply click here and follow these instructions


Receive the latest medical news on your Google homepage.

Add to Google

The 60 seconds challenge: Receive the latest medical news on your Google homepage within 60 seconds - simply click here and follow these instructions





Privacy Policy   |    Disclaimer      

MediLexicon International Ltd, UK Office: +44 (0) 1625 415 347
MediLexicon International Ltd © 2009 All rights reserved.